-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Xenon Pharmaceuticals, Raises Price Target to $80

Benzinga·03/09/2026 17:45:31
Listen to the news
Needham analyst Serge Belanger maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Buy and raises the price target from $58 to $80.